A synthetic peptide for use as a blocking control in assays to test for specificity of PLEKHG2 antibody, Alternative Names: PLEKHG2 control peptide, PLEKHG2 antibody Blocking Peptide, Anti-PLEKHG2 Blocking Peptide, pleckstrin homology domain containing, family G, with RhoGef domain member 2 Blocking Peptide, CLG Blocking Peptide, DKFZp667J2325 Blocking Peptide, FLJ00018 Blocking Peptide, FLJ22458 Blocking Peptide, FLJ38638 Blocking Peptide, PLEKHG2, PLEKHG-2, PLEKHG 2, PLEKHG-2 Blocking Peptide, PLEKHG 2 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
PLEKHG2
(Pleckstrin Homology Domain Containing, Family G (With RhoGef Domain) Member 2 (PLEKHG2))
Synonyme
ARHGEF42 Peptide, CLG Peptide, AI194308 Peptide, Clg Peptide, Cslg Peptide, pleckstrin homology and RhoGEF domain containing G2 Peptide, pleckstrin homology domain containing, family G (with RhoGef domain) member 2 Peptide, PLEKHG2 Peptide, Plekhg2 Peptide
Hintergrund
PLEKHG2 may be a transforming oncogene with exchange activity for CDC42. PLEKHG2 may be a guanine-nucleotide exchange factor (GEF) for RAC1 and CDC42.PLEKHG2 activated by the binding to subunits beta and gamma of the heterotrimeric guanine nucleotide-binding protein (G protein).